Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02372019 · ClinicalTrials.gov registry record · NA

Augmentation Study of A Computerized Treatment for Social Anxiety Disorder

A NA study, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
74
Enrollment target

NCT02372019: Completed NA study, sponsored by University of Texas at Austin.

NCT02372019 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02372019, a NA study, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
74 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether briefly reactivating a fear memory 10 minutes prior to administering a social anxiety treatment will enhance the durability of treatment effects.

Primary Outcome

The LSAS is a commonly used measure of social anxiety that measures fear as well as avoidance behaviors concerning social interactions. The study will use a computerized, self-report version of the LSAS, which has demonstrated little deviation from clinician-administered LSAS scores.

Interventions

  • BEHAVIORAL CBM With Active Fear Reactivation
  • BEHAVIORAL CBM With Inert Fear Reactivation
  • BEHAVIORAL Inert CBM With Inert Fear Reactivation

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2015-02
Est. Completion 2017-05
Phase NA
University of Texas at Austin

257 total trials

What the finished NCT02372019 record still lists

NCT02372019 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 3 interventions - of which CBM With Active Fear Reactivation is the first listed.

NCT02372019 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02372019 about?

NCT02372019 is a clinical study titled "Augmentation Study of A Computerized Treatment for Social Anxiety Disorder". The purpose of this study is to determine whether briefly reactivating a fear memory 10 minutes prior to administering a social anxiety treatment will enhance the durability of treatment effects.

What is the current status of trial NCT02372019?

This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2015-02. Estimated completion is 2017-05.

What interventions are being tested in trial NCT02372019?

The interventions under investigation include: CBM With Active Fear Reactivation (BEHAVIORAL), CBM With Inert Fear Reactivation (BEHAVIORAL), Inert CBM With Inert Fear Reactivation (BEHAVIORAL).

Who is sponsoring clinical trial NCT02372019?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02372019's enrollment target sits among peer trials

74 1082nd of 2000 higher than 912 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02372019, the US trial registry maintained by the National Library of Medicine. NCT02372019 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.